EMA begins rolling review of Chinese Covid-19 vaccine

The EMA said that studies suggest that the vaccine triggers the production of antibodies which may help protect against Covid-19. File picture

The European Medicines Agency (EMA) has started a rolling review of one of China’s Covid-19 vaccine.

The Beijing based company Sinovac is developing the inactivated jab and the review is based on preliminary results from lab and clinical studies.